International Journal of Medical and Pharmaceutical Research
2024, Volume-5, Issue-3
Original Research Article
Comparison of Negative Pressure Wound Therapy and Traditional Dressings in Diabetic Foot Ulcer Patients
Published
June 7, 2024
Abstract

Background: Diabetic foot ulcers (DFUs) pose a significant challenge in diabetes care,with varying treatments available. This study compared the efficacy of Negative Pressure Wound Therapy (NPWT) with traditional dressings in DFUs management. Methods: A prospective, randomized comparative study was conducted involving 120
patients with DFUs, divided equally between NPWT and traditional dressings groups. The primary outcomes measured were healing time, wound healing rates at 4, 8, and 12 weeks, infection rates, and incidence of complications. Results: NPWT significantly reduced the mean healing time to 6.8 weeks compared to 9.5 weeks for traditional dressings (p < 0.001). Healing rates at 4, 8, and 12 weeks were significantly higher in the NPWT group (30%, 60%, and 78%, respectively) compared to the traditional dressings group (18%, 40%, and 58%, respectively) with p-values of 0.045, 0.03, and 0.023. The NPWT group also showed a lower infection rate (10% vs. 25%, p =
0.015) and fewer complications, including rates of gangrene (3.3% vs. 10%, p = 0.038) and amputation (1.7% vs. 8.3%, p = 0.042). Conclusion: NPWT offers significant advantages over traditional dressings in the management of DFUs, including faster healing, higher healing rates, reduced infection rates, and lower incidence of severe complications. These findings support the preference for NPWT in DFU treatment protocols, considering individual patient conditions.

Recommended Articles
Loading Image...
Volume-5, Issue-3
Citations
958 Views
255 Downloads
Share this article
License
Copyright (c) International Journal of Medical and Pharmaceutical Research
pdf Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
All papers should be submitted electronically. All submitted manuscripts must be original work that is not under submission at another journal or under consideration for publication in another form, such as a monograph or chapter of a book. Authors of submitted papers are obligated not to submit their paper for publication elsewhere until an editorial decision is rendered on their submission. Further, authors of accepted papers are prohibited from publishing the results in other publications that appear before the paper is published in the Journal unless they receive approval for doing so from the Editor-In-Chief.
IJMPR open access articles are licensed under a Creative Commons Attribution-ShareAlike 4.0 International License. This license lets the audience to give appropriate credit, provide a link to the license, and indicate if changes were made and if they remix, transform, or build upon the material, they must distribute contributions under the same license as the original.
Logo
International Journal of Medical and Pharmaceutical Research
About Us
The International Journal of Medical and Pharmaceutical Research (IJMPR) is an EMBASE (Elsevier)–indexed, open-access journal for high-quality medical, pharmaceutical, and clinical research.
Follow Us
© Copyright IJMPR | All Rights Reserved